elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-28EB5F3C-1BC4-4ABD-A998-9FFDE293E690
Q27852097-28EB5F3C-1BC4-4ABD-A998-9FFDE293E690
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-28EB5F3C-1BC4-4ABD-A998-9FFDE293E690
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P577
Q27852097-28EB5F3C-1BC4-4ABD-A998-9FFDE293E690
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-28EB5F3C-1BC4-4ABD-A998-9FFDE293E690
rank
NormalRank
type
BestRank
Statement
P577
2013-03-01T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
2f5991a07a44b46a7c04b7df8ae2834f